Obesity is a highly prevalent chronic illness that affects over 40% of adults in the United States. Patients with obesity have a greater risk of developing multiple health conditions, including breast cancer in postmenopausal women. So far, research does not support the same obesity-breast cancer link in premenopausal women. Keep reading to learn more about the relationship between these two conditions
GLP-1 Weight Loss Medication
The link between obesity and breast cancer
Obesity is clinically defined as a body mass index (BMI) of 30 or higher. Those with obesity have a heightened risk of developing “obesity-related” cancers. Thirteen types of cancer currently fall into this group and breast cancer is one of them. Obesity isn’t the sole risk factor for obesity-related cancers.
The link between obesity and breast cancer risk varies based on menopause status and breast cancer type. While people with obesity are about 1.3 times more likely to develop postmenopausal breast cancer, research suggests premenopausal women with obesity are less likely to get breast cancer. Experts are still trying to understand this inverse relationship; they don’t recommend weight gain as a way to prevent breast cancer on account of the health risks associated with obesity.
Obesity isn’t the only weight-related factor linked to an elevated risk of breast cancer. One study found that high body fat levels increase the risk of breast cancer, even when BMI is normal. More studies are needed to better understand this relationship.
In addition to being a risk factor for developing breast cancer, obesity is also associated with negative health outcomes after diagnosis. These include lower survival rates, shorter periods of time until disease recurrence, and worse treatment outcomes.
Why obesity Is a risk factor
It’s useful to understand which processes might be involved in obesity’s relationship with breast cancer. Here are some possible mechanisms:
- Increased estrogen production: Higher estrogen levels are associated with elevated breast cancer risk. Excess adipose tissue, or fat tissue, can lead to a higher conversion of estrogen precursors to estrogen, which may elevate overall risk.
- Chronic inflammation: Chronic inflammation is gradual inflammation that occurs over a period of months or years. Obesity is a known cause of chronic inflammation, especially in adipose tissue, which can be associated with tumor formation and growth.
- Metabolic factors: People with obesity are at greater risk for developing chronic conditions including insulin resistance, which is characterized by an impaired response to insulin. This means muscle, fat and liver cells can’t efficiently use glucose from the blood for energy. As a result, the pancreas over-produces insulin. Obesity-related inflammation is also thought to promote the development of insulin resistance. Higher levels of insulin resistance have been associated with a higher incidence of breast cancer and higher all-cause mortality.
Mitigating obesity as a risk factor
Obesity is a treatable risk factor for cancer. Treatment for obesity always includes diet changes and increased exercise. Exercise is a key component in weight management, and one 2018 study found that exercise, in general, is associated with a 13% lower risk of breast cancer. Exercise has also been shown to reduce recurrence of and death from breast cancer. Experts recommend 75 to 150 minutes of moderate-intensity activity, such as brisk walking, per week. On top of healthy lifestyle habits, it’s important to be proactive about preventive care and to keep up with recommended cancer screenings. If diet and exercise alone are unable to help you meet your weight loss goals, medications may help.
GLP-1 Weight Loss Medication
References
- NIH. National Cancer Institute. Obesity and Cancer
- CDC. Overweight and Obesity. Adult Obesity Facts
- Obesity and Breast Cancer: A Paradoxical and Controversial Relationship Influenced by Menopausal Status
- CDC. Obesity and Cancer
- Body Mass Index and Breast Cancer Risk According to Postmenopausal Estrogen-Progestin Use and Hormone Receptor Status
- Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention
- Association of Body Fat and Risk of Breast Cancer in Postmenopausal Women With Normal Body Mass Index
- Obesity and Breast Cancer: The Estrogen Connection
- Endogenous estrogen and postmenopausal breast cancer: a quantitative review
- Role of inflammation in obesity-related breast cancer
- Diabetes, Obesity, and Breast Cancer
- Obesity and endocrine-related cancer: The important role of IGF-1
- Association between diabetes status and breast cancer in US adults: findings from the US National Health and Nutrition Examination Survey
- How Your Weight May Affect Your Risk of Breast Cancer